Ampio Pharma (AMPE) Founder, CEO Extend Lock-Up Agreements
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives, management and directors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ampio Pharma (AMPE) Mentioned Cautiously in Blog
- Facebook (FB) Debuts Conversion Lift; Will Improve Impact Analytics for Advertisers
- Twitter (TWTR) Brings Video Editing, Sharing to Mobile App
Create E-mail Alert Related CategoriesInsiders' Blog
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!